API Holdings, the parent of digital health platform PharmEasy, has appointed Rahul Guha as Managing Director and CEO, effective August 27, 2025. The move marks the exit of Siddharth Shah from the top post, concluding the operational tenure of the company’s founding team and signalling a renewed focus on profitability and operational discipline.
API Holdings Limited, headquartered in Mumbai, operates as India’s largest integrated digital healthcare platform. Through its flagship brand PharmEasy and diagnostics subsidiary Thyrocare Technologies, the group provides online pharmacy services, diagnostic testing, and health management solutions across the country.
Leadership Transition:
The company announced that Rahul Guha, currently CEO of Thyrocare and President of Operations at API Holdings, will assume the role of Managing Director and Chief Executive Officer from August 27, 2025. He succeeds Siddharth Shah, the last operational co-founder, who will transition to the position of Vice Chairman.
Since the 2020 merger of PharmEasy with offline drug distributor Ascent Health, API’s co-founders — including Dharmil Sheth, Dhaval Shah, Harsh Parekh, and Hardik Dedhia — had jointly navigated the company through rapid expansion and industry challenges. Their planned exits began in 2024, leaving Shah as the final founder in an executive capacity until now.
Financial Context and Challenges:
The leadership change comes amid API’s efforts to stabilise finances. In FY24, the group reported a 15% year-on-year revenue decline to $660 million, though net losses narrowed by half to $300 million through cost-control measures. PharmEasy’s valuation, which once peaked at $5.6 billion, dropped to around $700 million during a $216 million funding round in April 2024 led by Manipal Group’s Ranjan Pai, Prosus, and other investors.
Strategic Priorities:
Under Guha’s leadership, API is expected to priorities operational efficiency, profitability, and strategic clarity across its pharmacy and diagnostics businesses. Guha will continue as Thyrocare CEO while leading API Holdings, ensuring integration between the two verticals.
The company has indicated that an initial public offering — first filed in 2021 and withdrawn in 2022 — remains a possibility, though no timeline has been confirmed.
READ MORE ON